Sauer M A, Rifka S M, Hawks R L, Cutler G B, Loriaux D L
J Pharmacol Exp Ther. 1983 Feb;224(2):404-7.
Crude marijuana extract competed with estradiol for binding to the estrogen receptor of rat uterine cytosol. Condensed marijuana smoke also competed with estradiol for its receptor. Pure delta 9-tetrahydrocannabinol, however, did not interact with the estrogen receptor. Ten delta 9-tetrahydrocannabinol metabolites also failed to compete with estradiol for its receptor. Of several other common cannabinoids tested, only cannabidiol showed any estrogen receptor binding. This was evident only at very high concentrations of cannabidiol. Apigenin, the aglycone of a flavinoid phytoestrogen found in cannabis, displayed high affinity for the estrogen receptor. To assess the biological significance of these receptor data, estrogen activity was measured in vivo with the uterine growth bioassay, using immature rats. Cannabis extract in large doses exhibited neither estrogenic nor antiestrogenic effects. Thus, although estrogen receptor binding activity was observed in crude marijuana extract, marijuana smoke condensate and several known components of cannabis, direct estrogenic activity of cannabis extract could not be demonstrated in vivo.
粗制大麻提取物与雌二醇竞争结合大鼠子宫胞质溶胶中的雌激素受体。浓缩大麻烟雾也与雌二醇竞争其受体。然而,纯Δ9-四氢大麻酚不与雌激素受体相互作用。十种Δ9-四氢大麻酚代谢物也未能与雌二醇竞争其受体。在测试的其他几种常见大麻素中,只有大麻二酚显示出任何雌激素受体结合。这仅在非常高浓度的大麻二酚时才明显。芹菜素是大麻中发现的一种黄酮类植物雌激素的苷元,对雌激素受体表现出高亲和力。为了评估这些受体数据的生物学意义,使用未成熟大鼠通过子宫生长生物测定法在体内测量雌激素活性。大剂量的大麻提取物既不表现出雌激素作用也不表现出抗雌激素作用。因此,尽管在粗制大麻提取物、大麻烟雾浓缩物和大麻的几种已知成分中观察到雌激素受体结合活性,但大麻提取物的直接雌激素活性在体内无法得到证实。